Therapeutic intervention of AGE/RAGE pathway in NAFLD
- Research Opportunity
- Honours students
- Number of Honour Places Available
- Medicine and Radiology
- Austin Health
|Prof Peter Angusemail@example.com||Personal web page|
|Dr Chandana Herathfirstname.lastname@example.org||9496 2549||Personal web page|
Summary Identify potentially modifiable factors that exacerbate liver injury and fibrosis in NAFLD and to develop therapies that can prevent or slow liver scarring.
Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the adult population and is now a major cause of liver disease related premature illness and death in Australia. Currently there is no established drug therapy and treatment is largely based on lifestyle modification, which is difficult to achieve in most patients. As a result, there remains a major need to identify potentially modifiable factors that exacerbate liver injury and fibrosis in NAFLD and to develop therapies that can prevent or slow liver scarring.
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.
Research Group / Unit / Centre
Research NodeAustin Health
MDHS Research library
Explore by researcher, school, project or topic.